Drug Type Small molecule drug |
Synonyms Ivaltinostat-PPA |
Target |
Mechanism HDAC inhibitors(Histone deacetylase inhibitors) |
Therapeutic Areas |
Active Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
RegulationOrphan Drug (US) |
Molecular FormulaC24H33N3O4 |
InChIKeyAUGCSOFQTDKPSO-RGVLZGJSSA-N |
CAS Registry936221-33-9 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pancreatic adenocarcinoma metastatic | Phase 2 | US | 15 Aug 2022 | |
Acute Myeloid Leukemia | Phase 2 | KR | 30 Jan 2022 | |
COVID-19 | Phase 2 | KR | 30 Jan 2022 | |
Hepatocellular Carcinoma | Phase 2 | KR | 30 Jan 2022 | |
Myelodysplastic Syndromes | Phase 2 | KR | 30 Jan 2022 | |
Pancreatic Ductal Adenocarcinoma | Phase 2 | KR | 30 Jan 2022 | |
Advanced Pancreatic Adenocarcinoma | Phase 2 | KR | 01 Mar 2016 | |
Secondary malignant neoplasm of pancreas | Phase 2 | KR | 01 Mar 2016 | |
Advanced Malignant Solid Neoplasm | Phase 1 | KR | 01 Sep 2010 | |
Idiopathic Pulmonary Fibrosis | Preclinical | US | 03 Jan 2023 |
Not Applicable | - | whkkwemayh(dmmaqzojrc) = kswvaezctc nepwopwxnr (coiodlypsq ) | Positive | 18 May 2018 | |||
whkkwemayh(dmmaqzojrc) = ouhhtawlhp nepwopwxnr (coiodlypsq ) | |||||||
Phase 1 | - | iyptkgcavz(zbijbxbtnw) = dyymkpkckt kgtxraakmr (enzdrprqpl ) View more | - | 20 May 2012 |